Company: NGVT
Filing Date: 2025-02-19
Form Type: 10-K
Source: 0001653477-25-000015
Chunk: 513

Company: Ingevity Corp
Filing Date: 2025-02-19
Form: 10-K
Item: Item 1
Chunk 513
---
, which included approximately $4.0 million realized from the Performance Chemicals repositioning actions initiated in 2023.

32

Restructuring and other (income) charges, net

Years Ended December 31, 2024, 2023, and 2022

 Years Ended December 31,In millions202420232022Work force reductions and other$2.3 $12.5 $— Performance Chemicals' repositioning172.7 113.1 — Restructuring charges$175.0 $125.6 $— Alternative feedstock transition— 22.1 — North Charleston plant transition11.2 14.8 — Business transformation costs— 7.7 13.8 Other (income) charges, net$11.2 $44.6 $13.8 Restructuring and other (income) charges, net (1)$186.2 $170.2 $13.8 

_______________

(1) See Note 15 for more information. 

Goodwill impairment charge

Years Ended December 31, 2024, 2023, and 2022

Goodwill impairment charge of $349.1 million for the year ended December 31, 2024 within our Performance Chemicals reporting unit. See Note 8 for more information.

Acquisition-related costs

Years Ended December 31, 2024, 2023, and 2022 

Acquisition costs were $0.3 million, $3.6 million, and $5.0 million for the years ended December 31, 2024, 2023, and 2022, respectively. For the twelve months ended December 31, 2024, 2023, and 2022, all charges related to the integration of Ozark Materials into our Performance Chemicals segment. See Note 16 for more information.

Other (income) expense, net

Years Ended December 31, 2024, 2023, and 2022

 Years Ended December 31,In millions202420232022(Gain) loss on strategic investments (1)$11.4 $(19.3)$— Foreign currency transaction (gain) loss4.2 3.7 2.3 CEO severance charges4.8 — — Loss on CTO resales (2)52.7 22.0